NCT05015764View on ClinicalTrials.gov

Reprieve Cardiovascular System for the Treatment of Subjects With Acute Decompensated Heart Failure Mechanistic Study

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 12, 2021

Primary Completion Date

May 2, 2022

Study Completion Date

May 2, 2022

Conditions
Heart Failure
Interventions
OTHER

Fluid Management

Removal of excess extracellular fluid using diuretics

DEVICE

Reprieve Cardiovascular System

System with Fluid Management Module

Trial Locations (1)

Unknown

Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi

All Listed Sponsors
lead

Reprieve Cardiovascular, Inc

INDUSTRY